FilingReader Intelligence
Cipla Bengaluru facility passes USFDA inspection
August 5, 2025 at 03:49 AM UTC•By FilingReader AI
Cipla's Bommasandra facility in Bengaluru received a Voluntary Action Indicated (VAI) classification following a USFDA inspection from May 26-30, 2025.
The company was notified of the positive outcome on August 4th, indicating satisfactory regulatory standing for the manufacturing site.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:CIPLA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Cipla publishes news
Free account required • Unsubscribe anytime